[Federal Register Volume 88, Number 29 (Monday, February 13, 2023)]
[Notices]
[Pages 9279-9288]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-02930]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Establishment of the Coronavirus and Other Respiratory Viruses 
Division

AGENCY: Centers for Disease Control and Prevention (CDC), the 
Department of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: CDC has modified its structure. This notice announces the 
establishment of the Coronavirus and other Respiratory Viruses Division 
and other organizational components within the National Center for 
Immunization and Respiratory Diseases (NCIRD), Deputy Director for 
Infectious Diseases (DDID), CDC.

DATES: This reorganization was approved by the Secretary of HHS on 
January 24, 2023, and became effective February 8, 2023.

SUPPLEMENTARY INFORMATION: Part C CDC of the Statement of Organization, 
Functions, and Delegations of Authority of the Department of Health and 
Human Services (45 FR 67772-76, dated October 14, 1980, and corrected 
at 45 FR 69296, October 20, 1980, as amended most recently at 87 FR 
51670-51675, dated August 23, 2022) is amended to reflect the 
reorganization of NCIRD, DDID, CDC. Specifically, the changes are as 
follows:
    Under Part C, Section C-B, Organization and Functions, delete and/
or update functional statements for NCIRD in their entirety and replace 
with the following:

NCIRD (CVG)

    NCIRD prevents disease, disability, and death through immunization 
and by control of respiratory and related diseases. In carrying out its 
mission, NCIRD: (1) Provides leadership, expertise, and service in 
laboratory and epidemiological sciences, and in immunization program 
delivery; (2) conducts applied research on disease prevention and 
control; (3) translates research findings into public health policies 
and practices; (4) provides diagnostic and reference laboratory 
services to relevant partners; (5) conducts surveillance and research 
to determine disease distribution, determinants, and burden nationally 
and internationally; (6) responds to disease outbreaks domestically and 
abroad; (7) ensures that public health decisions are made objectively 
and based upon the highest quality of scientific data; (8) provides 
technical expertise, education, and training to domestic and 
international partners; (9) provides leadership to internal and 
external partners for establishing and maintaining immunization, and 
other prevention and control programs; (10) develops, implements, and 
evaluates domestic and international public health policies; (11) 
communicates information to increase awareness, knowledge, and 
understanding of public health issues domestically and internationally, 
and to promote effective immunization programs; (12) aligns NCIRD's 
focus with the overall strategic goals of CDC; (13) synchronizes all 
aspects of CDC's pandemic preparedness and response from

[[Page 9280]]

strategy through implementation and evaluation; and (14) implements, 
coordinates, and evaluates programs across NCIRD, DDID, and CDC to 
optimize public health impact.

Office of the Director (OD) (CVG1)

    (1) Provides leadership, expertise, and service in laboratory and 
epidemiological sciences for respiratory and vaccine preventable 
diseases and in immunization program delivery; (2) provides diagnostic 
and reference laboratory services to relevant partnerships; (3) works 
with DDID to ensure spending plans, budget planning, and budget 
execution are in line with the overall infectious disease strategies 
and priorities; (4) ensures that NCIRD's strategy is executed by the 
divisions and aligned with overall CDC goals; (5) co-develops execution 
strategies for NCIRD with the division directors; (6) provides program 
and science quality oversight; (7) builds leadership at the division 
and branch levels; (8) evaluates the strategies, focus, and 
prioritization of the division research, program, and budget 
activities; (9) identifies and coordinates synergies between NCIRD and 
relevant partners; (10) ensures that policy development is consistent 
and appropriate; (11) facilitates research and program activities by 
providing leadership support; (12) proposes resource priorities 
throughout the budget cycle; (13) ensures scientific quality, ethics, 
and regulatory compliance; (14) fosters an integrated approach to 
research, program, and policy activities; (15) liaises with HHS and 
other domestic and international immunization and respiratory disease 
partners as well as with NCIRD divisions; (16) coordinates center's 
emergency response activities related to immunization issues and 
complex acute respiratory infectious disease emergencies; (17) applies 
communication science, media principles, and web design to support 
NCIRD and CDC's efforts to reduce morbidity and mortality caused by 
vaccine-preventable and respiratory diseases; ensuring that 
communication distributed by the center is timely, accurate, clear and 
relevant to intended audiences; (18) provides guidance for key 
scientific and laboratory services in the functional areas of 
extramural research (research and non-research), human studies 
oversight and review, regulatory affairs; activities in the area of 
space planning, advising, coordination and evaluation, safety 
management and coordination, and shared services in controlled 
correspondence, and programmatic services in the area of workforce and 
career development; (19) provides and coordinates center-wide 
administrative, management, and support services in the areas of fiscal 
management, personnel, travel, procurement, facility management, and 
other administrative services; and (20) manages the coordination of 
workforce development and succession planning activities, and provides 
human capital management, planning, and training consultation services.

Office of Informatics (CVG12)

    (1) Manages all IT project costs, schedules, performances, and 
risks; (2) provides expertise in leading application development 
techniques in information science and technology to affect the best use 
of resources; (3) performs technical evaluation and/or integrated 
baseline reviews of all information systems' products and services 
prior to procurement to ensure software purchases align with DDID 
strategy; (4) provides access to quality data in support of 
programmatic data analysis; (5) coordinates all enterprise-wide IT 
security policies and procedures with the Office of the Chief 
Information Officer and relevant enterprise governance bodies, such as 
the IT and Data Governance; (6) ensures operations are in accordance 
with CDC Capital Planning and Investment Control guidelines; (7) 
ensures adherence to CDC enterprise architecture guidelines and 
standards; (8) consults with users to determine IT needs and to develop 
strategic and action plans; (9) participates in the evolution, 
identification, development, or adoption of appropriate informatics 
standards in conjunction with the DDID; and (10) provides leadership in 
initiatives focused on data and IT modernization that aligns with CDC 
agency goals for public health data modernization.

Office of Policy (CVG13)

    (1) Serves as liaison with CDC/OD and other Centers, Institute, 
Offices (CIO) policy offices, HHS and other government agencies, and 
external partners on policy, program, legislative, and budgetary issues 
related to NCIRD; (2) leads annual NCIRD budget formulation and 
development of appropriations materials; (3) provides expertise and 
guidance for strategic planning and performance measurement; (4) 
oversees and coordinates NCIRD accountability activities, including 
Government Accountability Office and Inspector General studies, audits 
and reviews, as well as center responses to Freedom of Information Act 
requests, and correspondence from partners, Congress, and the public; 
(5) creates and provides briefing documents and materials for executive 
leadership within NCIRD, DDID, and CDC on NCIRD's policy and 
programmatic issues; (6) conducts legislative monitoring and analysis; 
(7) provides NCIRD with leadership and advice in the management of 
congressional and governmental relations; (8) works with NCIRD 
divisions to coordinate policy requests across the center; (9) manages 
cross-cutting policy issues within NCIRD and, as appropriate, with 
other CIO and OD offices within CDC; and (10) collaborates across NCIRD 
and CDC to build and maintain partnerships that support NCIRD's 
domestic and global goals and initiatives, including promoting 
vaccination across the lifespan; prevention, detection and control of 
respiratory diseases; and preparedness for pandemics and other 
respiratory disease outbreaks.

Office of Health Communications Science (CVG15)

    (1) Supports NCIRD's mission through the planning, development, 
implementation, and evaluation of science-based health communication 
activities and programs; (2) applies communication science, media 
principles, and web design to support NCIRD and CDC's efforts to reduce 
morbidity and mortality caused by vaccine-preventable and respiratory 
diseases; (3) conducts projects that translate scientific and medical 
information into messages for a variety of audiences using an array of 
media/formats; (4) improves understanding of vaccine benefits and risks 
among partners, healthcare providers and public audiences; (5) improves 
understanding among specialized audiences such as policy-makers and 
public health officials nationally and internally of NCIRD's work; (6) 
supports public health partners via technical assistance and other 
methods; (7) demonstrates best practices in writing using plain 
language and health literacy principles, creating culturally 
appropriate materials; (8) coordinates CDC's pandemic influenza 
communication preparedness activities; (9) leads the development and 
implementation and evaluation of major cross cutting communication 
campaigns for vaccines preventable diseases; and (10) conducts 
behavioral and communication research to ensure that messages and 
strategies are clear, relevant, and potentially impactful to intended 
audiences.

[[Page 9281]]

Office of Management & Operations (CVG16)

    (1) Plans, coordinates, directs and provides advice and guidance on 
management and administrative operations of NCIRD in the areas of 
fiscal management, personnel, human capital, workforce training and 
development, travel, records management, facility management, and other 
administrative related services; (2) prepares and distributes annual 
budget plans and provides overall direction for planning and management 
oversight of allocated resources; (3) provides guidance on NCIRD 
requirements related to intramural and extramural activities, 
purchases, and agreements; (4) reviews the effectiveness and efficiency 
of the operation and administration of all NCIRD programs; (5) develops 
and implements administrative policies and procedures; (6) prepares 
special reports and studies in the administrative management areas; and 
(7) coordinates workforce development and succession planning 
activities for and with the center, providing human capital management, 
planning, and training consultation services to manage evolving 
workforce needs and skillset requirements.

Office of Science (CVG17)

    (1) Links strategies and priorities of the primarily programmatic-
focused NCIRD divisions with those of primarily disease-based 
divisions; (2) facilitates development and ongoing implementation of 
integrated infectious respiratory disease (including influenza) 
surveillance, research and prevention, and control activities across 
the divisions, both domestically and globally, including supporting 
implementation of NCIRD's respiratory diseases strategic prevention 
priorities; (3) meets with other CDC CIOs working in the area of 
respiratory diseases; (4) coordinates and facilitates NCIRD's overall 
respiratory and vaccine preventable disease scientific/research agenda; 
(5) assumes responsibility for the protection of human research 
subjects, scientific review, clearance of manuscripts and other written 
materials; (6) provides planning and coordination of overall 
surveillance strategies, preparedness, response, and prevention 
effectiveness related to a center-wide public health scientific agenda 
and quantifies how programs and activities promote cost-effective and 
high impact prevention strategies with respect to immunization and 
other vaccine-preventable disease programs; (7) provides leadership 
(agency and center-wide) for vaccine-preventable and respiratory 
disease surveillance to include guidance and coordination of NCIRD 
surveillance activities and systems, leadership on issues related to 
internal and external integration of CDC surveillance activities, and 
alignment with enterprise-wide data and IT governance and modernization 
strategy; (8) coordinates, facilitates, and integrates domestic and 
international respiratory and vaccine-preventable disease surveillance 
activities through existing methods while developing new approaches, 
tools, and analyses for these activities; (9) fosters a 
multidisciplinary approach to epidemiology, statistics, informatics, 
laboratory methods, and evaluation; (10) provides leadership, 
expertise, and service in laboratory science; (11) represents NCIRD's 
interests in cross-cutting laboratory services in DDID which include, 
but are not limited to, laboratory information systems, quality 
management systems, and bioinformatics; (12) ensures a safe working 
environment in NCIRD laboratories; (13) collaborates effectively with 
other centers and offices in carrying out its functions; (14) manages 
CDC's intellectual property (e.g., patents, trademarks, copyrights) and 
promotes the transfer of new technology from CDC research to the 
private sector to facilitate and enhance the development of diagnostic 
products, vaccines, and products to improve occupational safety; (15) 
provides oversight, guidance and coordination relating to the 
application of social and behavioral sciences to support impactful 
research and programs to achieve healthy behavior change; (16) 
coordinates and tracks health equity science and program activities 
within NCIRD and with partners; and (17) supports research, 
surveillance, education, training, and program development to achieve 
healthy equity and reduce health disparities.

Office of Global Health, Preparedness, and Response (CVG18)

    (1) Advises NCIRD and CDC leadership on global health and pandemic 
preparedness related to current and known threats such as coronavirus 
disease 2019 (COVID-19) and influenza, and to emerging pandemic 
threats; (2) provides strategic leadership for CDC in the areas of 
pandemic preparedness and response and global health related to 
respiratory and vaccine preventable diseases including establishing 
NCIRD priorities, promoting science, policies, and new programs; (3) 
coordinates NCIRD efforts related to funding and budgets for global 
health security and pandemic preparedness and response; (4) supports 
NCIRD's work across CDC and the federal government on global health 
security, respiratory diseases, and pandemic preparedness and response; 
and (5) coordinates across NCIRD, CDC, and with partners to plan for 
and exercise responses to pandemic and other threats.

Immunization Services Division (ISD) (CVGB)

    ISD protects individuals and communities from vaccine-preventable 
diseases across the lifespan through: provision of federal funds and 
contracts to purchase and distribute vaccines; provision of technical 
and financial support for immunization programs, partners, and for 
efforts to increase equity in immunization; provision of provider, 
patient, and public immunization education and communication; 
surveillance of vaccination coverage and vaccine attitudes; and 
evaluation and research to identify root causes of under vaccination 
and vaccine inequity.

ISD Office of the Director (CVGB1)

    (1) Supports ISD's mission through leadership across the branches 
related to domestic vaccination efforts and vaccine-preventable disease 
preparedness and response elements and links strategies and priorities 
with other NCIRD divisions; (2) facilitates development and ongoing 
implementation of vaccination coverage surveillance, health services 
and economic research, and program evaluation across ISD branches; (3) 
provides direct management, oversight, and execution of national 
vaccine supply contracts; (4) provides direct management and execution 
of procurement requisitions, contracts, and cooperative agreements, and 
performs administrative tasks related to initiating, processing, and 
maintaining interagency agreements; (5) provides direct management and 
execution of human resources, administrative functions, and workplace 
climate and facility management across ISD; (6) provides guidance 
related to and protection of human research subjects, Office of 
Management and Budget and Paperwork Reduction Act compliance, and 
scientific initiatives across ISD branches; (7) furthers data strategy, 
IT governance, and data-related policy across the division, through 
coordinated work across ISD; (8) provides leadership for activities in 
ISD related to health equity, including improving equity in access to 
vaccination opportunities and vaccination coverage rates across 
different populations; (9) coordinates programs and activities to help 
achieve

[[Page 9282]]

and sustain increased vaccination coverage among uninsured and 
underinsured adults; (10) coordinates and supports activities across 
the division related to cross-cutting topics, such as emergency 
preparedness, clinical expertise, jurisdictional coordination, and 
vaccine confidence and demand; (11) provides direct management and 
oversight for division-wide communications and policy, including 
liaisons to the branches; (12) serves as liaison to other policy 
offices, other government agencies, and external partners on policy, 
program, legislative, and budgetary issues related to ISD; (13) manages 
and executes cross-cutting communications to support ISD's mission to 
protect individuals and communities from vaccine-preventable diseases; 
(14) promotes internal awareness of division initiatives and guidance 
through timely, accurate, clear, and relevant communications; (15) 
provides technical assistance to ISD branches in the development and 
revision of operational manuals, job aids, and web pages; (16) manages 
the all-jurisdiction email account by maintaining distribution lists 
(in collaboration with ISD branches) and disseminating messaging to 
jurisdictions and partners on behalf of ISD and its branches and 
programs.

Immunization Operations and Services Branch (CVGBB)

    (1) Serves as CDC's primary interface with the state, local, and 
territorial health department immunization programs funded by 
cooperative agreements related to Vaccines for Children (VFC), Section 
317, and other programs that support immunization across the lifespan, 
supporting them with development, implementation, assessment, and 
promotion of vaccination-related activities with the goal of achieving 
and sustaining high and equitable vaccination coverage levels across 
the lifespan; (2) serves as ISD's lead in the management, processing, 
and monitoring of the funding provided through the cooperative 
agreements related to VFC, Section 317, and other programs supporting 
immunization across the lifespan; (3) administers the operations of the 
VFC, Section 317, and other appropriate programs for eligible 
jurisdictions; (4) provides technical assistance to jurisdictions on 
program implementation for child, adolescent, and adult activities, 
including implementation of all components of the cooperative 
agreements; (5) provides subject-matter expertise on adult immunization 
program implementation and guidance; (6) monitors performance of 
recipients of the cooperative agreements related to VFC, Section 317, 
and other programs supporting immunization across the lifespan; (7) 
oversees management and operations of jurisdiction-vaccination provider 
engagement programs and efforts (i.e., VFC and Section 317 quality 
assurance, quality improvement [in cooperation with the Applied 
Research, Implementation Science, and Evaluation Branch] perinatal 
hepatitis B prevention, and vaccine accountability [in cooperation with 
the Vaccine Supply and Assurance Branch]).

Vaccine Supply and Assurance Branch (CVGBC)

    (1) Manages logistics for the public sector vaccine supply chain; 
(2) supports supply chain immunization activities carried out by state, 
local, and territorial health department immunization programs and 
their enrolled providers, funded by cooperative agreements related to 
VFC, Section 317, or other programs that support immunization across 
the lifespan; (3) provides planning, purchasing, ordering, 
distribution, and management of vaccine supply shortages and 
constraints; (4) establishes and manages contracts for the purchase of 
vaccines across the lifespan; (5) creates and maintains pediatric 
vaccine stockpiles for the VFC program; (6) tracks and monitors 
seasonal influenza vaccine distribution; (7) maintains subject matter 
expertise and provides technical assistance related to jurisdiction 
vaccine planning activities and vaccine storage and handling; (8) 
serves as the business owner for CDC's vaccine order management system 
(VTrckS); engage in strategic planning for the modernization and 
defect/enhancement testing for VTrckS [in collaboration with the 
Informatics and Data Analytics Branch]; provides support and training 
for jurisdiction users of VTrckS; (9) manages contracts that provide 
technical, operational, and user support for VTrckS; (10) uses vaccine 
purchase and order data to support activities within the branch, 
respond to internal and external data calls, provide jurisdiction 
feedback, and collaborate on CDC-sponsored evaluation activities.

Informatics and Data Analytics Branch (CVGBE)

    (1) Provides leadership, technical assistance, technology tools, 
data quality assurance, and resource support to develop capacity for a 
nationwide network of fully operational and integrated immunization 
information systems (IISs); (2) increases the quality of IIS data 
across the lifespan and system functionality and security by 
identifying, developing, implementing, promoting, and evaluating 
standards and best practices in collaboration with other federal 
agencies and partners; (3) supports exchange of high-quality IIS data 
between jurisdictions' clinical, administrative, public health 
immunization stakeholders, and federal partners; (4) promotes the 
effective use of IIS data and systems to support vaccination providers, 
public health programs, and other immunization stakeholders; (5) 
monitors, evaluates, and reports on IIS data to improve operations and 
immunization program outcomes; (6) maintains informatics capability and 
information technology tools to support immunization programs at the 
provider, jurisdiction, and federal level; and (7) influences health 
information technology policies and standards to improve the quality of 
immunization data submitted by healthcare systems.

Surveillance and Epidemiology Branch (CVGBG)

    (1) Leads domestic vaccination coverage and vaccine confidence and 
demand assessment across the lifespan; (2) collects, analyzes, and 
disseminates accurate and timely data for action--including data 
related to vaccination coverage, utilization data, and related 
information from available data sources (including but not limited to 
data from national surveys, health systems, and medical claims) in 
conjunction with subject matter experts in other ISD branches as 
appropriate; (3) assesses equity in vaccination coverage and vaccine 
confidence and demand among racial/ethnic minorities and other 
populations disproportionately affected by health inequities; (4) in 
conjunction with other ISD branches, assists national, state, and local 
immunization programs in collection, analysis, interpretation, and use 
of vaccination coverage and vaccine confidence and demand assessment to 
guide policy and program activities; (5) conduct and manage the family 
of surveys under the National Immunization Survey contract to assess 
vaccination coverage and behavioral and social drivers of vaccination; 
and (6) evaluate and find methods to improve the usefulness of existing 
and potential new data sources for assessment of vaccination coverage 
and behavioral and social drivers of vaccination.

Health Education and Communication Branch (CVGBH)

    (1) Provides education and communication materials and resources

[[Page 9283]]

to improve knowledge and acceptance of vaccines among healthcare 
providers and the public to increase vaccine uptake across the 
lifespan, thus reducing vaccine-preventable diseases; (2) provides 
education and communication materials and resources to improve clinical 
knowledge among healthcare providers and other healthcare personnel 
about the proper storage, handling, preparation, and administration of 
vaccines to help ensure vaccine safety; (3) collaborates across NCIRD 
to develop communication strategies to increase vaccinations across the 
lifespan; (4) develops and disseminates, by a variety of mechanisms, 
domestic immunization messages, materials, educational resources, and 
training for healthcare providers and patients related to ISD's 
scientific, clinical, and programmatic work; (5) provides technical 
assistance for healthcare providers, state and local health 
departments, and other groups on communication science and 
implementation, scalable programmatic action, and evaluation of 
education and communication strategies to improve vaccine confidence 
and vaccination coverage rates; (6) provides continuing education 
credits for immunization-related education and training products; (7) 
leads the Advisory Committee on Immunization Practices (ACIP) Child and 
Adolescent and Adult Immunization Schedules Work Group and General Best 
Practices Work Group, participates in other ACIP work groups, and 
develops and promotes resources related to ACIP schedules and 
recommendations; (8) develops and promotes social media and other 
initiatives to combat immunization misinformation and/or disinformation 
and promote vaccine confidence and equity; (9) collaborates with ISD 
policy, communication, and implementation science functions to address 
communication science needs; (10) responds to clinically or 
programmatically relevant immunization inquiries via NIP-INFO, an email 
inquiry service for health departments and healthcare providers; and 
(11) develops vaccine information statements as required by law.

Applied Research, Implementation Science, and Evaluation Branch (CVGBJ)

    (1) Synthesizes literature/data and conducts health services and 
economic research to understand reasons for under-vaccination and 
vaccine inequities across the lifespan; (2) designs strategies to 
increase vaccination coverage, equity, and confidence, and assess 
strategy effectiveness; (3) translates and adapts evidence-based 
strategies for scalable programmatic action; (4) designs ISD's quality 
improvement activities; define their standards and requirements for 
implementation and for data collection, reporting, and sharing; (5) 
provides technical assistance and facilitate research and evaluation 
capacity building among CDC-funded immunization programs; (6) supports 
program effectiveness activities conducted by CDC-funded immunization 
programs; (7) monitors trends in access to vaccines, vaccine knowledge, 
attitudes, and perceptions, including vaccine confidence; (8) provides 
division-wide subject matter expertise on evaluation; and (9) conducts 
over-arching evaluation of the national immunization program to inform 
program improvement.

Field Services Branch (CVGBK)

    (1) Provides support to the state, local, and territorial health 
department immunization programs funded by cooperative agreements 
related to VFC, Section 317, and other programs supporting immunization 
across the lifespan for immunization program implementation through the 
assignment of CDC staff as requested by jurisdictions to address gaps 
in capacity; (2) based on the agreements with each jurisdiction, 
provides official supervision and high-level training of staff assigned 
to health departments to assist with jurisdiction immunization program 
operations; and (3) supports the needs and provides tools for staff 
embedded in jurisdictions and local health departments.

Partnership and Health Equity Branch (CVGBL)

    (1) Collaborates with public health partner groups to achieve 
national immunization program goals and scalable programmatic action; 
(2) partners with national, state, local, and community-based 
organizations to achieve greater equity in access to and demand for 
administration of vaccines across the lifespan; (3) partners with non-
governmental professional organizations to support immunization 
recommendations, and education, communication, training, and quality 
improvement strategies; (4) partners with other federal agencies to 
ensure coordination of efforts related to equity and vaccination; (5) 
provides technical assistance and capacity-building support to funded 
and unfunded partners to achieve immunization and equity goals; (6) 
facilitates a shared learning forum and learning opportunities for 
partners to provide strategies and resources on promoting vaccine 
equity; (7) monitors opportunities for future partnerships, especially 
those that serve adult, underrepresented, and disproportionately 
affected populations; (8) evaluates funded partnerships to ensure that 
projects are meeting workplan objectives and other requirements; and 
(9) monitors and supports needs of immunization partners external to 
ISD.

Influenza Division (ID) (CVGD)

    ID improves global control and prevention of seasonal and novel 
influenza and improves influenza pandemic preparedness and response. In 
collaboration with domestic and global partners, ID: (1) Builds 
surveillance and response capacity; (2) monitors and assesses influenza 
viruses and illness; (3) improves vaccines and other interventions; and 
(4) applies research to provide science-based enhancement of prevention 
and control policies and programs.

ID Office of the Director (CVGD1)

    (1) Provides vision, leadership, and direction for the division; 
(2) fosters external partnerships and cross-cutting activities that 
support quality science and strong global partnerships; (3) provides 
leadership and guidance in policy formulation; (4) provides technical 
expertise and leadership for national and international pandemic 
preparedness activities; and (5) provides technical expertise for 
communications, public health guidance, informatics, epidemiologic, and 
laboratory science, and reagent resources.

Virology, Surveillance, and Diagnosis Branch (CVGDB)

    (1) Conducts comprehensive antigenic, phenotypic, genotypic, 
structural, and evolutionary characterization of human and animal 
influenza viruses; (2) performs genetic and antigenic pandemic risk 
assessment of novel influenza viruses; (3) develops and evaluates novel 
and seasonal candidate vaccine viruses; (4) provides expert guidance on 
influenza vaccine virus selection; (5) develops methods to detect and 
characterize influenza viruses; and (6) trains and supports 
laboratories that perform influenza testing.

Epidemiology and Prevention Branch (CVGDC)

    (1) Conducts surveillance, research, modeling, and forecasting 
activities to better understand and monitor the epidemiology of 
influenza viruses and disease; (2) improves understanding of

[[Page 9284]]

the effectiveness of influenza antiviral drugs, vaccines, and non-
pharmaceutical interventions; (3) assists state and local health 
departments to conduct surveillance and optimize activities related to 
the detection and response to emerging and novel influenza viruses; (4) 
supports influenza vaccine policy; and (5) supports influenza pandemic 
preparedness activities.

Immunology and Pathogenesis Branch (CVGDE)

    (1) Increases knowledge and improves understanding of immunity and 
immune correlates of protection; (2) develops and improves vaccines; 
(3) determines virus and host factors that impact virulence and 
transmission of influenza viruses; (4) conducts immunologic and 
virologic pandemic risk assessment of novel influenza viruses; and (5) 
trains and supports laboratories that perform immunologic testing.

Global Influenza Branch (CVGDG)

    (1) Supports capacity building to improve global surveillance for 
influenza viruses and disease; (2) conducts surveillance, program 
evaluations, research, and modeling activities to improve our 
understanding of global influenza; (3) assists with detection and 
response to emerging and novel influenza viruses outside the United 
States; (4) promotes prevention and control activities including the 
expanded use of influenza vaccines globally; and (5) supports global 
pandemic preparedness activities.

Division of Viral Diseases (DVD)(CVGE)

    DVD prevents disease, disability, and death through immunization 
and control of enteric, and related viral diseases. In carrying out 
this mission, DVD: (1) Conducts surveillance and related activities to 
determine patterns of infection and disease and impact of prevention 
programs; supports and provides technical assistance to state and local 
health departments to conduct surveillance and related activities; (2) 
conducts epidemiologic and laboratory studies to define patterns of, 
and risk factors for, infection, disease, and disease burden; estimates 
vaccine effectiveness, determines cost effectiveness of vaccines, and 
evaluates other aspects of immunization programs; identifies and 
evaluates non-vaccine prevention strategies; and provides epidemiologic 
and laboratory expertise to other Nation Centers (NCs), collaborators, 
and partners on vaccination and other prevention strategies; (3) 
provides consultation on viral vaccine preventable, and enteric 
diseases, and the use of vaccines and other measures to prevent 
infections; (4) provides consultation and support and/or participates 
in investigations of viral vaccine preventable and enteric viral 
diseases domestically and internationally, and recommends appropriate 
control measures; (5) provides scientific leadership and advice, 
analyzes and synthesizes available data, and develops science-based 
statements for use of viral vaccines to ACIP and other groups to 
support the development and evaluation of immunization practices and 
policies domestically and internationally; (6) provides laboratory 
support for surveillance and epidemiologic studies and maintains 
reference/diagnostic services and expertise; (7) conducts studies of 
immunology and pathogenesis of disease and the biologic, biochemical, 
genetic and antigenic characteristics of the agents; (8) develops, 
evaluates, and improves diagnostic methods and reagents, and transfers 
assays and techniques to other public health laboratories; (9) 
facilitates and participates in the development and evaluation of 
antiviral compounds, vaccines, and vaccination programs; (10) provides 
and supports public health training; (11) responds to and assists 
internal and external partners on other public health problems of 
national and international significance, as needed; (12) provides 
technical support to state immunization programs for all aspects of 
vaccine-preventable diseases and their vaccines; (13) provides 
leadership in vaccine science; and (14) supports CDC's Immunization 
Safety Office (ISO) in vaccine safety risk assessment and leadership in 
vaccine safety risk management.

DVD Office of the Director (CVGE1)

    (1) Manages, directs, coordinates and monitors the activities of 
the division; (2) provides overall guidance and direction for the 
division's epidemiologic, surveillance, research, laboratory, outbreak 
response, and other scientific and immunization-related activities; (3) 
sets short- and long-term programmatic goals and outlines strategic 
achievements in alignment with NCIRD priorities; (4) monitors and 
evaluates progress of division- and branch-led programs, promotes 
program improvements, and facilitates strategic decision-making; (5) 
provides analysis and facilitates strategic use of public health 
policies and operational procedures for continuous risk management and 
operational efficiencies; (6) identifies needs and allocates resources 
for ongoing and new initiatives and assigns responsibilities for their 
development; (7) communicates division public health messages to 
internal and external audiences via conventional media, web, social 
media, professional organizations, and other venues, to maximize impact 
of division programs; (8) provides leadership and guidance in policy 
formulation, partnerships, program planning and development, program 
management, and operations of the division; (9) provides division 
leadership, expertise, and technical collaboration for the application 
of statistics, economics, operations research, geospatial analysis, 
other quantitative sciences, informatics, and data management to 
prevent disease, disability and death through immunization and control 
of enteric, and other viral diseases; (10) provides next-generation 
sequencing laboratory support for method development and bioinformatics 
infrastructure across division and with external partners; (11) 
provides leadership for division informatics, data, and surveillance 
modernization initiatives; (12) prepares, reviews, and coordinates 
informational, scientific, and programmatic documents; (13) assures the 
overall quality of the science conducted by the division and provides 
guidance and new initiatives to support the enhancement of laboratory 
quality and bio-safety; (14) oversees and facilitates the division's 
scientific support to other groups within CDC and national and 
international public health and healthcare partners; (15) guides and 
facilitates efficient coordination and cooperation for administrative, 
programmatic, and scientific activities within the division and with 
other groups inside and outside of CDC; and (16) supports the division 
related to Management & Operations functions such as budget, program 
resource management, extramural administration, and human resource 
management.

Polio and Picornavirus Branch (CVGEC)

    (1) Provides laboratory assistance, technical expertise and support 
for surveillance and related activities to monitor impact of 
vaccination and other prevention programs, and determine patterns of 
infection and disease due to poliovirus and other human picornaviruses; 
(2) provides laboratory support and technical expertise for 
epidemiologic and laboratory studies to define patterns and risk 
factors for infection, disease, and disease burden; (3) studies 
vaccine-related issues; (4) identifies and evaluates non-vaccine

[[Page 9285]]

prevention strategies; (5) provides laboratory consultation and 
technical expertise regarding use of vaccines and other measures to 
prevent infections to other NCs, collaborators, and partners; (6) 
provides laboratory and epidemiologic consultation and support and/or 
participates in investigations of national and international outbreaks 
of viral vaccine-preventable and enteric viral diseases; (7) provides 
laboratory leadership and technical expertise to develop science-based 
statements to Global Polio Eradication Initiative, ACIP, and other 
groups to support the development and evaluation of immunization 
practices and policies in the United States and internationally; (8) 
provides epidemiology and laboratory consultation and support and/or 
participates in investigations of national and international outbreaks 
of viral diseases, and recommends appropriate control measures; (9) 
provides scientific leadership and advice, in both epidemiologic and 
laboratory areas; (10) provides support for surveillance and 
epidemiologic studies and maintains reference/diagnostic services and 
expertise; (11) conducts studies of immunology and pathogenesis of 
disease and the biology, biochemical, genetic, and antigenic 
characteristics of the agents; (12) develops, evaluates, and improves 
diagnostic methods and reagents, transfers assays and techniques to 
national and international public health laboratories, and provides and 
supports training for laboratorians; (13) facilitates and participates 
in the development and evaluation of antiviral compounds, vaccines, and 
vaccination programs; (14) responds to and assists internal and 
external partners on other public health problems of national and 
international significance as needed; and (15) serves as the National 
Reference Laboratory (poliovirus and enteroviruses) and World Health 
Organization (WHO) Global Polio Specialized Reference Laboratory.

Viral Vaccine-Preventable Diseases Branch (CVGED)

    (1) Conducts surveillance to determine patterns of infection and 
disease, provides laboratory assistance, technical expertise, and 
support for surveillance and related activities to monitor the impact 
of vaccination on the prevention of viral disease; (2) conducts 
epidemiologic and laboratory studies to define patterns of and risk 
factors for infection, disease, and disease burden; (3) estimates 
vaccine effectiveness, evaluates other aspects of immunization 
practices; (4) identifies and evaluates non-vaccine prevention 
strategies; (5) provides epidemiological and laboratory expertise and 
technical support to other NCs, collaborators, and partners across 
center working groups on vaccines and other prevention strategies; (6) 
supports the development of vaccine practices and policies by providing 
consultation and epidemiologic and laboratory expertise to other 
federal agencies, state health departments, ministries of health, WHO, 
Pan American Health Organization (PAHO), private industry, academia, 
and other governmental organizations on viral vaccine-preventable 
diseases, and on the use of vaccines and other measures to prevent 
infections; (7) provides epidemiologic and laboratory consultation and 
support and/or participates in investigations of national and 
international outbreaks of viral vaccine-preventable diseases and 
recommends appropriate control measures; (8) assists internal and 
external partners on other public health problems of national and 
international significance; (9) provides scientific leadership and 
advice, analyzes available data, and develops science-based statements 
for viral vaccines to the ACIP and other groups to support the 
development and evaluation of immunization practices and policies in 
the United States and internationally; (10) responsible for human 
papilloma virus (HPV), measles, mumps, rubella (MMR), zoster, and 
varicella vaccine policy in the United States by working with ACIP; 
(11) provides and supports public health training; (12) responds to 
public inquires and prepares communication materials; (13) works with 
health economists to determine cost effectiveness of vaccination 
strategies; (14) provides laboratory support for surveillance and 
epidemiologic studies and maintains reference and diagnostic services 
and expertise; (15) assists in investigation of adverse events 
following vaccination; (16) conducts studies of immunology and 
pathogenesis of disease and the biological, biochemical, genetic, and 
antigenic characteristics of viral agents; (17) develops, evaluates, 
and improves diagnostic methods and reagents; (18) transfers assays and 
techniques to other public health laboratories; (19) provides and 
supports laboratory training; (20) serves as the National Reference 
Laboratory for MMR, and varicella zoster virus and the PAHO Regional 
and WHO Global Specialized Laboratory for measles and rubella; (21) 
collaborates with CDC's HPV laboratory in conducting epidemiologic 
investigations; (22) facilitates and participates in the development 
and evaluation of vaccines, and vaccination programs; and (23) conducts 
studies to measure the immune response to viral vaccines and population 
immunity.

Viral Gastroenteritis Branch (CVGEE)

    (1) Provides epidemiologic and laboratory assistance to studies and 
related activities to better understand the evolution, (molecular) 
epidemiology and immunity of rotavirus, norovirus, and other 
gastroenteritis viruses; (2) provides consultation on the safety and 
impact of rotavirus vaccination and other prevention programs 
(rotavirus, norovirus); (3) provides consultation and technical 
assistance to state and local health departments to monitor the burden 
of disease and epidemiology of gastroenteritis virus infections; (4) 
provides consultation and support on the research and development of 
new rotavirus vaccines and other prevention technologies; (5) provides 
consultation, support and/or participates in investigations of national 
and international outbreaks of viral vaccine-preventable and other 
enteric viral diseases, and recommends appropriate control measures; 
(6) provides scientific leadership and advice, analyzes available data, 
and develops science-based statements for rotavirus vaccines to ACIP 
and other groups to support the development and evaluation of 
immunization practices and policies in the United States and 
internationally; (7) provides and supports public health training; (8) 
responds to and assists internal and external partners on other public 
health problems of national and international significance, as needed; 
(9) serves as the National Reference Laboratory for rotavirus, 
norovirus and other agents of viral gastroenteritis; and (10) serves as 
the WHO Global Reference Center for Rotavirus and other agents of viral 
gastroenteritis.

Division of Bacterial Diseases (DBD) (CVGG)

    DBD prevents and controls illness and death from vaccine-
preventable and other respiratory bacterial diseases, in the United 
States and worldwide, through leadership in epidemiologic and 
laboratory science and vaccine policy. DBD plays a critical role in 
outbreak response, surveillance and epidemiologic research, laboratory 
diagnosis and pathogen characterization, and vaccine development, and 
provides scientific support for development of vaccine policy and 
public health guidance to control vaccine-preventable and other 
respiratory bacterial diseases. In carrying out its mission, DBD: (1) 
Conducts and assists state and local

[[Page 9286]]

health departments to conduct surveillance, including surveillance for 
antimicrobial resistance in the bacteria under the division's purview, 
and prepares and distributes surveillance information; (2) conducts 
epidemiologic and laboratory studies to define etiology, patterns of 
disease, disease burden, and risk factors; determines safety, 
effectiveness, and cost effectiveness of vaccines, updates immunization 
policy, and evaluates other aspects of immunization practices; and 
identifies and evaluates other (non-vaccine) prevention strategies; (3) 
provides consultation on the use of bacterial vaccines and other 
measures to prevent infections; (4) participates, provides 
consultation, and supports investigations of outbreaks, epidemics, and 
other public health problems in the United States and internationally, 
and recommends and evaluates appropriate control measures; (5) provides 
scientific leadership for development and evaluation of immunization 
policy related to vaccines in the United States by compiling and 
analyzing information on vaccine-preventable diseases and helping 
prepare statements on bacterial vaccines for the ACIP and other groups 
to support the development and evaluation of immunization policy; in 
international settings, provides guidance and technical expertise on 
vaccine-preventable disease policy development; (6) provides laboratory 
support for surveillance and epidemiologic studies and reference 
diagnostic services, to state and local health departments, other 
federal agencies, and national and international health organizations; 
(7) conducts studies of the biology, biochemical, genetic, and 
antigenic characteristics, immunology, and pathogenesis of disease; (8) 
develops, analyzes, and improves diagnostic methods and reagents; (9) 
facilitates development and evaluation of immunologic compounds, 
vaccines, and vaccination programs; (10) provides intramural and 
extramural assistance with professional training; (11) assists internal 
and external partners with other public health problems of national and 
international significance when needed; (12) provides technical support 
to state immunization programs for all aspects of vaccine-preventable 
diseases and their vaccines; (13) provides leadership in vaccine 
science; and (14) supports CDC's ISO in vaccine safety risk assessment 
and leadership in vaccine safety risk management.

DBD Office of the Director (CVGG1)

    (1) Directs, coordinates, and manages the programs and activities 
of the division; (2) provides leadership and guidance on policy, 
program planning and development, program management, and operations; 
(3) coordinates or assures coordination with the appropriate CDC, DDID, 
and NCIRD offices on administrative and program matters; (4) reviews, 
prepares, and coordinates congressional testimony and briefing 
documents related to bacterial respiratory and vaccine-preventable 
diseases, and analyzes programmatic and policy implications of 
legislative proposals; (5) serves as CDC, DDID, and NCIRD's primary 
internal and external communications contact regarding bacterial 
respiratory and vaccine-preventable disease issues; (6) advises CDC, 
DDID, and NCIRD on policy and communications matters concerning the 
division's programs and activities; (7) assures the overall quality of 
the science conducted by the division; (8) coordinates division 
activities on cross-cutting agency initiatives; (9) guides and 
coordinates division laboratories to implement quality management 
systems and maintain safety; (10) guides and facilitates efficient 
coordination and cooperation for administrative, programmatic, and 
scientific activities within the division, and with other groups in and 
outside of CDC; (11) provides statistical consultation for 
epidemiologic and laboratory research studies conducted by the 
division, including developing new methods for statistical 
applications; and (12) provides a center of excellence for the study of 
immunologic response to infection, vaccination, and therapeutic 
interventions against bacterial diseases.

Respiratory Diseases Branch (CVGGB)

    (1) Provides assistance in control of epidemics and works to 
improve control and prevention of respiratory and other syndromes 
caused by Streptococcus pneumoniae, group A and group B streptococci, 
and atypical respiratory bacteria (Legionella, Mycoplasma, and 
Chlamydia species), as well as community-acquired drug resistant 
bacterial infections, community-acquired pneumonia, otitis media, and 
neonatal sepsis; (2) develops, implements, and evaluates prevention 
methods for these diseases, including vaccines and non-vaccine 
strategies; (3) provides consultation and support to domestic and 
international partners on use of vaccines and other prevention measures 
to reduce bacterial respiratory diseases; (4) coordinates activities 
within and outside the division related to Active Bacterial Core 
surveillance with the Emerging Infections Program states, and assists 
with coordination of other surveillance platforms that include 
bacterial respiratory diseases; (5) provides reference and diagnostic 
activities for respiratory bacterial diseases and for the 
identification of unknown gram positive cocci; (6) develops and 
evaluates new diagnostic methods for bacterial respiratory pathogens; 
(7) develops, maintains, and implements genetic analyses of bacteria to 
enhance surveillance programs, outbreak investigations, and public 
health research; and (8) collaborates with other CDC groups, state and 
federal agencies, ministries of health, WHO, PAHO, private industry, 
academia, and other governmental organizations involved in public 
health.

Meningitis and Vaccine Preventable Diseases Branch (CVGGC)

    (1) Provides assistance in control of endemic and epidemic disease 
and exploits opportunities to improve control and prevention of 
bacterial illness including: meningococcal disease, Haemophilus 
influenzae infections, diphtheria, pertussis, tetanus, and bacterial 
meningitis syndrome; (2) provides reference and diagnostic activities 
for agents causing these diseases; (3) provides cross-cutting vaccine 
responsibilities for DBD and develops, implements, and evaluates 
prevention strategies for these bacterial diseases; (4) develops, 
implements, and evaluates vaccines and vaccine candidates for these 
bacterial diseases; (5) conducts surveillance and epidemiological 
research for meningococcal disease, H. influenzae infections, 
diphtheria, pertussis, tetanus, and bacterial meningitis syndrome; (6) 
maintains WHO Collaborating Center for Control and Prevention of 
Epidemic Meningitis; and (7) collaborates with other CDC groups, state 
and federal agencies, ministries of health, WHO, PAHO, private 
industry, and other governmental organizations involved in public 
health.

Coronavirus and Other Respiratory Viruses Division (CRVD) (CVGH)

    CRVD prevents disease, disability, and death through immunization 
and control of coronaviruses, respiratory, and other related viral 
diseases. In carrying out this mission, CRVD: (1) Conducts surveillance 
and related activities to determine patterns of infection and disease 
and impact of prevention programs; (2) supports and provides technical 
assistance to state and local health departments to conduct 
surveillance and related activities; (3) conducts epidemiologic and 
laboratory studies to define patterns of, and risk factors for, 
infection, disease, and

[[Page 9287]]

disease burden; (4) estimates vaccine effectiveness, determines cost 
effectiveness of vaccines, and evaluates other aspects of immunization 
programs; (5) identifies and evaluates non-vaccine prevention 
strategies and provides epidemiologic and laboratory expertise to other 
NCs, collaborators, and partners on vaccination and other prevention 
strategies; (6) provides consultation on viral vaccine preventable, and 
enteric diseases, and the use of vaccines and other measures to prevent 
infections; (7) provides consultation and support and/or participates 
in investigations of respiratory viral diseases domestically and 
internationally, and recommends appropriate control measures; (8) 
analyzes and synthesizes available data to support the development and 
evaluation of immunization practices and policies domestically and 
internationally; (9) provides laboratory support for surveillance and 
epidemiologic studies and maintains reference/diagnostic services and 
expertise; (10) conducts studies of immunology and pathogenesis of 
disease and the biologic, biochemical, genetic and antigenic 
characteristics of the agents; (11) develops, evaluates, and improves 
diagnostic methods and reagents; (12) transfers assays and techniques 
to other public health laboratories; (13) facilitates and participates 
in the development and evaluation of antiviral compounds, vaccines, and 
vaccination programs; (14) provides and supports public health 
training; (15) responds to and assists internal and external partners 
on other public health problems of national and international 
significance, as needed; (16) provides technical support to state 
immunization programs for all aspects of vaccine-preventable diseases 
and their vaccines; (17) provides leadership in vaccine science; and 
(18) supports CDC's ISO in vaccine safety risk assessment and 
leadership in vaccine safety risk management.

CRVD Office of the Director (CVGH1)

    (1) Manages, directs, coordinates and monitors the activities of 
the division; (2) provides overall guidance and direction for the 
division's epidemiologic, surveillance, research, laboratory, outbreak 
response, and other scientific and immunization-related activities; (3) 
sets short- and long-term programmatic goals and outlines strategic 
achievements in alignment with NCIRD priorities; (4) monitors and 
evaluates progress of division- and branch-led programs, promotes 
program improvements, and facilitates strategic decision-making; (5) 
provides analysis and facilitates strategic use of public health 
policies and operational procedures for continuous risk management and 
operational efficiencies; (6) identifies needs and allocates resources 
for ongoing and new initiatives and assigns responsibilities for their 
development; (7) communicates division public health messages to 
internal and external audiences via conventional media, web, social 
media, professional organizations, and other venues, to maximize impact 
of division programs; (8) provides leadership and guidance in policy 
formulation, partnerships, program planning and development, program 
management, and operations of the division; (9) provides division 
leadership, expertise, and technical collaboration for the application 
of statistics, economics, operations research, geospatial analysis, 
other quantitative sciences, informatics, and data management to 
prevent disease, disability and death through immunization and control 
of enteric, and other viral diseases; (10) provides next-generation 
sequencing laboratory support for method development and bioinformatics 
infrastructure across division and with external partners; (11) 
provides leadership for division informatics, data, and surveillance 
modernization initiatives; (12) prepares, reviews, and coordinates 
informational, scientific, and programmatic documents; (13) assures the 
overall quality of the science conducted by the division and provides 
guidance and new initiatives to support the enhancement of laboratory 
quality and bio-safety; (14) oversees and facilitates the division's 
scientific support to other groups within CDC and national and 
international public health and healthcare partners; (15) guides and 
facilitates efficient coordination and cooperation for administrative, 
programmatic, and scientific activities within the division and with 
other groups inside and outside of CDC; (16) coordinates program and 
Division-level pandemic preparedness activities related to current and 
known threats such as COVID-19 and preparedness for future or emerging 
threats; (17) advises NCIRD and CDC leadership in the areas of pandemic 
preparedness and response and global health related to respiratory and 
vaccine preventable diseases including establishing CRVD priorities, 
promoting science, policies, and new programs; (18) coordinates across 
NCIRD, CDC, and with partners to plan for and exercise responses to 
pandemic and other threats; and (19) supports the division and all 
branches through a management and operations hub, providing functional 
support such as budget, program resource management, extramural 
administration, and human resource management.

Coronavirus and Other Respiratory Viruses Laboratory Branch (CVGHB)

    (1) Designs and conducts studies of the biological, genetic, and 
antigenic characteristics of non-influenza respiratory viruses 
including SARS-CoV-2, the virus the causes COVID-19, and the immunology 
and pathogenesis of associated diseases; (2) designs and conducts 
laboratory-related activities to support surveillance and epidemiologic 
studies, and to monitor impact of vaccination and other respiratory 
virus prevention measures; (3) provides laboratory support and 
technical expertise for studies to define patterns and risk factors for 
respiratory virus infections, diseases, and disease burden; (4) 
develops, evaluates, and improves diagnostic methods and reagents, 
conducts strain characterization for molecular epidemiology, and 
provides technology transfer support to public health laboratories for 
known and unknown viral etiologic agents for respiratory diseases of 
human and animal origin; (5) characterizes immune correlates of 
protection to advise partners on vaccine program policies; (6) 
determines virus and host factors that impact virulence and 
transmission of SARS-CoV-2 and other respiratory viruses; (7) 
facilitates and participates in the evaluation of respiratory virus 
countermeasures including prophylactics, therapeutics, and vaccines; 
(8) provides laboratory consultation and support for investigation of 
domestic and international respiratory viral disease outbreaks; (9) 
serves as CDC technical lead for providing guidance to WHO and key 
partners on classification of viral variants, performing variant risk 
assessments to inform COVID-19 vaccination policies, as well as in 
supporting platforms for genomic monitoring of coronaviruses and other 
respiratory viruses; (10) provides laboratory leadership and technical 
expertise to develop science-based statements to ACIP and other 
domestic and international collaborators to support the development and 
evaluation of practices, policies, and vaccine considerations for SARS-
CoV-2 and other respiratory viruses; and (11) provides technical 
assistance to international partners to conduct comprehensive 
antigenic, phenotypic, genotypic, structural, and evolutionary 
characterization of SARS-CoV2 and other respiratory viruses.

[[Page 9288]]

Coronavirus and Other Respiratory Viruses Surveillance and Prevention 
Branch (CVGHC)

    (1) Conducts surveillance and related activities to monitor 
patterns of respiratory virus infection and disease incidence and 
assess impact of interventions; (2) provides technical expertise and 
support to state and local health departments for surveillance and 
related activities; (3) provides expertise and support on data analysis 
and visualization of respiratory virus surveillance data for internal 
and external use; (4) performs applied modeling analyses to 
characterize disease burden and impact of interventions; (5) conducts 
vaccine effectiveness evaluations for coronaviruses and other 
respiratory viruses to support the development and evaluation of 
immunization practices and policies; (6) analyzes and synthesizes 
available data and develops science-based statements for potential 
respiratory viral vaccines to support the development and evaluation of 
immunization practices and policies related to coronaviruses and other 
respiratory virus vaccines by ACIP and other groups; (7) Coordinates 
quantitative science and data management planning, policy development, 
and project monitoring and evaluation; (8) designs, develops and 
conducts statistical, economic, cost, resource allocation, geospatial 
and other analyses and models; (9) develops data management 
methodologies and strategies for division activities and programs; and 
(10) collaborates with scientists, program experts, and senior public 
health officials throughout the division to implement strategies, 
models, and methodologies in support of enteric, and related viral 
disease research, surveillance, and prevention programs.

Coronavirus and Other Respiratory Viruses Epidemiology Branch (CVGHD)

    (1) Characterizes the spectrum of disease and sequelae from 
respiratory virus infections, including, but not limited to multisystem 
inflammatory syndrome and post-COVID conditions, the burden and 
incidence of sequelae, and risk factors for sequelae; (2) characterizes 
transmission dynamics and risk factors for coronavirus and other 
respiratory virus infections; (3) characterizes acute and long-term 
immunity to understand correlates of protection; (4) conducts and 
supports field epidemiologic studies to characterize unusual disease 
clusters and unexpected disease manifestations or trends of viral 
respiratory diseases; (5) provides consultation and technical 
assistance to state and local health departments and others in the 
investigation, management, mitigation and control of viral respiratory 
disease clusters and outbreaks; (6) evaluates the implementation, 
effectiveness and impact of community-level mitigation measures; (7) 
develops and updates public health guidance on community-based non-
pharmaceutical interventions for the prevention and control of 
respiratory viruses, such as masking, screening, quarantine, and 
isolation; and (8) provides consultation and technical support on 
clinical management and secondary prevention for respiratory viral 
diseases.

Global Coronavirus and Other Respiratory Viruses Branch (CVGHE)

    (1) Implements global respiratory virus surveillance including 
supporting enhanced epidemiologic and laboratory capacity and data 
analyses to improve understanding of the epidemiological 
characteristics, trends, and emergence of respiratory pathogens; (2) 
builds capacity for global surveillance and epidemic intelligence to 
detect and respond to respiratory events including those of pandemic 
potential; (3) assists global partners in pandemic preparedness 
activities; (4) provides support and/or participates in investigations 
of international respiratory outbreaks including implementing 
appropriate control measures; (5) conducts research studies with global 
partners, division, and agency stakeholders to better understand burden 
of disease, impact of prevention programs, and molecular epidemiology 
of respiratory viruses; (6) provides technical assistance to global 
partners to conduct or support comprehensive antigenic, phenotypic, 
genotypic, structural, and evolutionary characterization of SARS-CoV-2 
and respiratory viruses; and (7) provides expertise to global partners 
in the development of evidence-based surveillance standards and 
methods.

Delegations of Authority

    All delegations and redelegations of authority made to officials 
and employees of affected organizational components will continue in 
them or their successors pending further redelegation, provided they 
are consistent with this reorganization.

(Authority: 44 U.S.C. 3101)

Xavier Becerra,
Secretary, Department of Health and Human Services.
[FR Doc. 2023-02930 Filed 2-10-23; 8:45 am]
BILLING CODE 4160-18-P